Exploring the potential of group therapy, the conversation highlights the complexities of regulatory negotiations with the FDA. The importance of having a licensed therapist in the co-therapy model is emphasized, while also considering how group settings can foster healing through shared experiences. Additionally, the shift towards cognitive behavioral conjoint therapy opens new avenues for therapeutic practices.
